Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Bronchiolitis
- Focus Therapeutic Use
- Acronyms NO-BRO
- Sponsors AIT
- 07 Aug 2017 According to an AIT Therapeutics Inc. media release, data from this trial is expected in the first half of 2018.
- 13 Mar 2017 Status changed from not yet recruiting to recruiting.
- 17 Feb 2017 New trial record